Aoki et al. performed high-dimensional and spatial profiling of immune cells in cHL using scRNA-seq, multicolour immunohistochemistry and imaging mass cytometry identifying a unique regulatory CD4+/FOXP3+ T cell-like subset that expressed lymphocyte activation gene 3 (LAG3). The gene discussed is FOXP3; the disease is classic Hodgkin lymphoma.